Summa Equity invests in Ivbar Institute

Summa Equity has invested in Ivbar Institute AB (“Ivbar”). Ivbar is a Swedish digital health company that has developed a big data analytics technology that enables improved management of healthcare through a focus on patient value. The platform improves transparency and provides unique levels of insights into both patient outcomes and resource allocation.

The investment was carried out through Summa Digital, a platform established for Summa Equity’s investments in companies within the big data sector. By establishing a joint platform for big data investments, Summa Equity aims at creating good conditions for synergies, for example in go-to-market and development processes.

Summa Equity has become the largest shareholder of Ivbar through the investment. Ivbar’s management remain shareholders of the company and retain their positions within the management.

Summa Equity was advised by Mannheimer Swartling in the transaction.